Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    " February 10, 2010":" March 12, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" February 10, 2010":" March 12, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection
Conditions: HIV;   HIV Infections
Intervention:
2 Completed A Safety Study of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo
3 Completed Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers
Condition: HIV Infections
Intervention: Drug: GSK1349572
4 Terminated Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
Condition: HIV Infections
Intervention: Drug: lopinavir/ritonavir plus maraviroc
5 Unknown  Evaluation of the Efficacy of Hydroxychloroquine in Decreasing Immune Activation in Asymptomatic HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
6 Completed HIV Vaccine Study in HIV Positive Patients
Condition: HIV Infections
Interventions: Biological: HIV-v (Low Dose);   Biological: HIV-v (High Dose);   Biological: HIV-v (Control)
7 Completed Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study
Conditions: HIV;   HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
8 Completed Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)
Condition: HIV Infection
Intervention:
9 Completed Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption
Condition: HIV Infection
Interventions: Biological: AGS-004;   Biological: Placebo
10 Completed TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients
Condition: HIV-Infections
Intervention: Drug: etravirine
11 Unknown  Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: DOT-HAART
12 Completed Study of PENNVAX™-B (Gag, Pol, Env) + Electroporation in HIV-1 Infected Adult Participants
Conditions: HIV-1 Infection;   HIV Infections
Intervention: Biological: PENNVAX-B
13 Completed
Has Results
Post-Licensure Safety Study of ISENTRESS™ (Raltegravir) in a United States Managed Care Network (MK-0518-268)
Condition: HIV-1 Infections
Intervention:
14 Completed
Has Results
Special Investigation of Kaletra in Pregnant Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
15 Completed
Has Results
Drug Use Investigation of Kaletra
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/ritonavir (Kaletra)
16 Completed Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy
Conditions: HIV Infection;   Antiretroviral Side Effects;   Lipodystrophy Syndrome Related to HIV Infection
Intervention: Device: Eutrophill
17 Enrolling by invitation " Arthrospira Platensis" as Nutrition Supplementation for Female Adult Patients Infected by HIV in Yaoundé Cameroon
Condition: HIV
Intervention: Dietary Supplement: Arthrospira platensis
18 Completed Reducing HIV Risk Among Mexican Youth
Conditions: HIV Infections;   AIDS;   Sexually Transmitted Diseases
Interventions: Behavioral: Adolescent Safer Sex Intervention;   Behavioral: Parent Safer Sex Communication Intervention;   Other: Adolescent Health Promotion Control Condition;   Other: Parent Health Promotion Control Condition
19 Completed PENTA Fosamprenavir Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Exposure to licensed dose of FPV (+/- 20% of 18mg/kg BID + RTV)
20 Completed
Has Results
Evaluation of Kaletra Therapy Over the Long-term
Condition: Human Immunodeficiency Virus
Intervention: Drug: Lopinavir/Ritonavir (Kaletra)

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.